Mette Stæhr Selected Research

Mette Stæhr Research Topics

3	Proteinuria 12/2020 - 08/2015
2	Hypertension (High Blood Pressure) 12/2020 - 01/2017
2	Albuminuria 12/2020 - 01/2017
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 08/2015
2	Endotoxemia 10/2013 - 08/2011
1	Inflammation (Inflammations) 12/2020
1	Diabetes Mellitus 12/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Diabetes Complications 12/2020
1	Neoplasms (Cancer) 01/2020
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Nephrosis 01/2017
1	Edema (Dropsy) 08/2015
1	Vascular Ring 08/2011

2	PlasminogenIBA 12/2020 - 08/2015
2	Fibrinolysin FDA Link 12/2020 - 08/2015
2	AldosteroneIBA 12/2020 - 01/2017
2	Amiloride (Midamor)FDA LinkGeneric 12/2020 - 08/2015
2	Epithelial Sodium ChannelsIBA 12/2020 - 08/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2015
1	Prorenin ReceptorIBA 12/2020
1	Angiotensin IIIBA 12/2020
1	ReninIBA 12/2020
1	VaccinesIBA 01/2020
1	AntigensIBA 01/2020
1	MethyltransferasesIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2017
1	prostasinIBA 01/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 08/2015
1	Puromycin AminonucleosideIBA 08/2015
1	SodiumIBA 08/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2011
1	LipopolysaccharidesIBA 08/2011

1	Immunotherapy 01/2020
1	Nephrectomy 01/2017